在Pichiapastoris中表达和描述Clostridium perfringens类型D的复合性epsilon毒素变体
Mauro Joaquin Manfredi1, Alejandra Edith Larsen1, Eduardo Carlos Mortola1
1Basic and Applied Microbiology Center (CEMIBA) School of Veterinary Sciences, National University of La Plata, Buenos Aires, Argentina.
Protein expression and purification
|May 18, 2025
概括
研究人员为牲畜疫苗开发了无毒的复合性毒素 (ETX) 变体. 这些亚单元疫苗在预防肠毒性病方面表现有前途,为目前的选择提供了具有成本效益的替代方案.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 来自Clostridium perfringens的埃普西隆毒素 (ETX) 在牲畜中引起致命的肠毒性,导致严重的经济损失.
- 目前针对肠毒性病的疫苗很昂贵,可能会产生不一致的免疫反应.
- 在ETX诊断和治疗的局限性需要改进的预防策略.
研究的目的:
- 生产和表征两个非毒性复合版本的毒素:截断的rETX和突变的rETXH106P.
- 评估这些重组毒素作为对ETX诱导疾病的亚单元疫苗候选人的潜力.
- 探索它们在肠毒性病诊断套件中的有用性.
主要方法:
- 在Pichia pastoris系统中克隆和表达截断和突变的ETX基因.
- 小规模培养和细胞毒性测试以确认重组蛋白质的无毒性.
- 对rETXH106P进行大规模培养条件的优化,以评估动力参数和表达水平.
主要成果:
- 截断的rETX和突变的rETXH106P都成功地被生成为无毒的重组聚.
- 细胞毒性测定证实,产生的重组蛋白质中没有毒性.
- rETXH106P显示出大规模生产的潜力,并调整了动力参数评估的条件.
结论:
- 非有毒的复合毒素变体,特别是rETXH106P,是针对肠毒性病的亚单元疫苗的有希望的候选人.
- 这些重组蛋白还可以成为开发诊断套件的有价值组件.
- 这项研究为更有效,更经济地预防由ETX引起的牲畜疾病提供了潜在的途径.
相关概念视频
Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...


